4//SEC Filing
Dayno Jeffrey M. 4
Accession 0001615993-25-000005
CIK 0001802665other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:25 PM ET
Size
10.6 KB
Accession
0001615993-25-000005
Insider Transaction Report
Form 4
Dayno Jeffrey M.
DirectorPRESIDENT, CEO
Transactions
- Exercise/Conversion
Common Stock
2025-12-12$8.22/sh+20,000$164,400→ 20,000 total - Sale
Common Stock
2025-12-12$40.11/sh−20,000$802,146→ 0 total - Sale
Common Stock
2025-12-12$40.11/sh−5,933$237,957→ 0 total - Exercise/Conversion
Stock Option
2025-12-12−20,000→ 0 totalExercise: $8.22Exp: 2027-11-13→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.28. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The stock option vests in five equal annual installments beginning on November 1, 2018.
Documents
Issuer
Harmony Biosciences Holdings, Inc.
CIK 0001802665
Entity typeother
Related Parties
1- filerCIK 0001615993
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 5:25 PM ET
- Size
- 10.6 KB